Welcome, Guest. Please login or register.
February 26, 2021, 07:39:45 pm

Login with username, password and session length

  • Total Posts: 55033
  • Total Topics: 4830
  • Online Today: 41
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 23
Total: 23


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Post–Hep C Cure, Liver Improvement in Those With Cirrhosis Isn’t Tied to HIV...  (Read 1300 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Among those with cirrhosis, curing hepatitis C virus (HCV) is associated with similar rates of improved liver health 12 weeks after direct-acting antiviral (DAA) treatment regardless of whether individuals have HIV coinfection.

Publishing their findings in the Journal of Viral Hepatology, researchers conducted a retrospective cohort study of 490 people with hep C and cirrhosis, including 270 with HIV coinfection and 220 without HIV. The study population was drawn from the HEPAVIR-DAA and GEHEP-MONO cohorts. All members were treated with DAAs and achieved a sustained virologic response 12 weeks after completing therapy (SVR12, considered a cure).



© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.